Cargando…
Immune Checkpoint Inhibitor-Induced Hepatic Injury: A Clinicopathologic Review
Although immune checkpoint inhibitors (ICIs) have been a revolutionary milestone in immuno-oncology, immune-related adverse events (irAEs) may occur due to enhanced T cell activation and immune dysregulation. The irAEs can occur as early as within days to reportedly as late as up to 26 weeks. They m...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815477/ https://www.ncbi.nlm.nih.gov/pubmed/36618338 http://dx.doi.org/10.14218/jctp.2022.00017 |